"{\"content\":{\"body\":\"[ \\n ](http://www.bshare.cn/share)\\n\\n[每经AI快讯，博拓生物(688767)1月14日晚间披露业绩预告，预计2021年净利润增加4亿元-4.5亿元。受德尔塔和奥密克戎等变种新冠病毒影响，欧洲、澳大利亚等国家和地区新冠感染病例数持续保持较大增长，对新冠抗原检测试剂需求大幅增加，直接导致了公司海外新冠检测试剂收入大幅增长。](http://www.nbd.com.cn/articles/2022-01-14/2089645.html)\",\"timestamp\":1642156840,\"title\":\"每经AI快讯\"},\"digest\":\"-t-TtLSBW9c-iV4lyHcXsKY7t-OztaQNgfQCVvQOF4I\",\"authorship\":{\"contributor\":\"0x5Ced0bddbf33e8c035AA41119d3723FF443f1FD8\",\"signingKey\":\"{\\\"crv\\\":\\\"P-256\\\",\\\"ext\\\":true,\\\"key_ops\\\":[\\\"verify\\\"],\\\"kty\\\":\\\"EC\\\",\\\"x\\\":\\\"mWtpp5D40MDGTj6nzsfnMrSkwaZr7F1bwysvHygZ95c\\\",\\\"y\\\":\\\"cPzj1X2t0jZWlJn8i0XKDpGNHpQ7Z4C_8Rfm4HOO-6E\\\"}\",\"signature\":\"FH5s6HyuOBPBwwyZF-tp9uKmB2mgl1yG10xEFeEYoLVNRO1za4X859iZ1Of-SaVMkpGehFsNWUHx0HyDc4cNfw\",\"signingKeySignature\":\"0xd58cab39a8b38b833ca65256443729dfa69b64b6886a4489fb880e0a1be9fdc467e5ef875f2372b2b493e8a3ed82a77acb00ce294dba101ad52cbb640377e6051b\",\"signingKeyMessage\":\"I authorize publishing on mirror.xyz from this device using:\\n{\\\"crv\\\":\\\"P-256\\\",\\\"ext\\\":true,\\\"key_ops\\\":[\\\"verify\\\"],\\\"kty\\\":\\\"EC\\\",\\\"x\\\":\\\"mWtpp5D40MDGTj6nzsfnMrSkwaZr7F1bwysvHygZ95c\\\",\\\"y\\\":\\\"cPzj1X2t0jZWlJn8i0XKDpGNHpQ7Z4C_8Rfm4HOO-6E\\\"}\",\"algorithm\":{\"name\":\"ECDSA\",\"hash\":\"SHA-256\"}},\"nft\":{},\"version\":\"12-21-2020\",\"originalDigest\":\"-t-TtLSBW9c-iV4lyHcXsKY7t-OztaQNgfQCVvQOF4I\"}"